ENT Devices – Market Insights – United States

The US ENT device market was severely impacted by the COVID-19 pandemic in 2020, but has already shown significant recovery in 2021 and 2022. Growth over the forecast period will be driven mainly by the nasal packing device segment, followed by the ENT RF and Powered Instruments market. In the previous iteration, sinus stent market revenues were anticipated to grow modestly, based on favorable clinical trial data and positive feedback from clinicians; however, analysis of recently published financial data has revealed slower than anticipated growth in sinus stent sales. As a result, sinus stent unit and revenue projections have been adjusted downward, relative to the previous market forecast.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for ENT devices in the US from 2019 through 2032.

ENT procedure volumes will grow slowly over the forecast period.

Which procedure types will see the greatest growth through 2032? What factors will drive this growth?

What are the factors hampering growth of some procedures?

Procedures performed in the office will rise over the forecast period.

What proportion of procedures are being performed in the office?

How will the rise in office-based procedures affect the competitive landscape and competitor strategies?

What are the factors contributing to and facilitating this shift?

What do medical practitioners predict regarding the current and future landscape of procedures and their related devices?

The introduction of innovative devices as alternative treatments for ENT conditions will drive overall market expansion.

How will drug-eluting sinus stents and balloon Eustachian tube dilation devices perform over the forecast period?

How will recent innovations in the myringotomy/tympanostomy segment affect the market?

What clinical trials are being conducted that could contribute to further growth?

Manufacturers are attempting to broaden their portfolios by entering into newer segments, giving competition to established market leaders.

Which segments are seeing new products by competitors entering the space?

How have recent mergers and acquisitions affected existing portfolios?

How will the market share of current leaders in this space be affected?

Table of contents